石药集团(01093.HK):蔡磊获委任为副主席及执行董事等职

Core Viewpoint - The announcement from the company indicates significant changes in its leadership structure, effective December 19, 2025, which may impact its strategic direction and operational management [1] Group 1: Leadership Changes - Zhang Cuilong will no longer serve as Vice Chairman, CEO, and authorized representative due to job relocation but will remain an executive director [1] - Cai Lei has been appointed as Vice Chairman, Executive Director, CEO, and authorized representative [1] - Wei Qingjie has been appointed as Vice Chairman, Executive Director, and Chief Operating Officer [1]

CSPC PHARMA-石药集团(01093.HK):蔡磊获委任为副主席及执行董事等职 - Reportify